Why is MedinCell SA ?
- Poor long term growth as Operating profit has grown by an annual rate 7.11% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -7.06
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 83.49%, its profits have risen by 40.3%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is MedinCell SA for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at EUR 5.65 MM
Fallen by 0% (YoY
Highest at EUR 71.9 MM
Highest at 3.53%
Highest at EUR 16.8 MM
Highest at EUR -3.63 MM
Highest at -21.63 %
Highest at EUR -6.17 MM
Highest at EUR -4.61 MM
Highest at EUR -0.12
Highest at 80.28 %
Here's what is working for MedinCell SA
Net Sales (EUR MM)
Operating Cash Flows (EUR MM)
Net Sales (EUR MM)
Operating Profit (EUR MM)
Operating Profit to Sales
Pre-Tax Profit (EUR MM)
Pre-Tax Profit (EUR MM)
Net Profit (EUR MM)
Net Profit (EUR MM)
EPS (EUR)
Cash and Cash Equivalents
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Depreciation (EUR MM)
Depreciation (EUR MM)
Here's what is not working for MedinCell SA
Debt-Equity Ratio






